A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
PHASE2CompletedINTERVENTIONAL
Enrollment
502
Participants
Timeline
Start Date
September 29, 2018
Primary Completion Date
April 15, 2020
Study Completion Date
April 15, 2020
Conditions
Parkinson's Disease
Interventions
DRUG
KW-6356
Oral administration
DRUG
Placebo
Oral administration
Trial Locations (1)
Unknown
Iwamizawa Neurology Clinic, Iwamizawa
All Listed Sponsors
lead
Kyowa Kirin Co., Ltd.
INDUSTRY
NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations | Biotech Hunter | Biotech Hunter